INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 99 filers reported holding INSTIL BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,262,000 | +4.8% | 673,905 | 0.0% | 0.57% | -19.5% |
| Q2 2022 | $3,113,000 | -57.0% | 673,905 | 0.0% | 0.71% | -58.4% |
| Q1 2022 | $7,244,000 | -37.2% | 673,905 | 0.0% | 1.71% | -54.9% |
| Q4 2021 | $11,531,000 | -4.3% | 673,905 | 0.0% | 3.80% | -13.2% |
| Q3 2021 | $12,046,000 | -7.5% | 673,905 | 0.0% | 4.38% | -18.2% |
| Q2 2021 | $13,020,000 | -5.6% | 673,905 | +22.5% | 5.35% | -7.9% |
| Q1 2021 | $13,794,000 | – | 550,000 | – | 5.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
| CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
| VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
| Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
| Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
| Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
| RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
| Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
| HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
| Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |